Prime Medicine, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA
PRME chart
What traders are saying about $PRME
Latest postsPrime Medicine, Inc. news
- Prime Medicine (NASDAQ:PRME) Stock Price Up 7.1% - Here's What Happened
MarketBeat ·
- First Prime Editing Trial for Wilson's Disease
조선일보 ·
- First Prime Editing Therapy Trial Targets Wilson’s Disease
조선일보 ·
- Prime Medicine, Inc. Estimates – NASDAQ:PRME
TradingView ·
- Prime Medicine (NASDAQ:PRME) Stock Price Down 8.1% - Here's Why
MarketBeat ·
- Scientists Just Rewrote Human DNA Inside the Body for the First Time
Gadget Review ·
- Prime editing rewrites DNA inside human body for the first time
The News International ·
- Prime Editing Rewrites DNA Inside a Patient’s Body for the First Time
Technology Org ·
- Prime Medicine launches first in-body prime editing trial for Wilson disease
DongA Science ·
- Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why
Yahoo Finance ·
- Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
Yahoo Finance ·
- Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity
barchart.com ·
Prime Medicine, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4.6M | $3.0M | $0 | $0 |
| Net income | -$201.1M | -$195.9M | -$198.1M | -$121.8M |
| Diluted EPS | $-1.35 | $-1.65 | $-2.18 | $-4.19 |
| Total assets (year end) | $342.7M | $297.5M | $193.9M | $360.3M |
| Cash and equivalents (year end) | $63.0M | $182.5M | $41.6M | $187.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Prime Medicine, Inc.
- Ticker
- PRME (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1894562
Frequently asked questions
What exchange is Prime Medicine, Inc. listed on?
Prime Medicine, Inc. trades on the Nasdaq under the ticker symbol PRME.
What industry is Prime Medicine, Inc. in?
Prime Medicine, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Prime Medicine, Inc. headquartered?
Prime Medicine, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Prime Medicine, Inc.'s fiscal year end?
Prime Medicine, Inc.'s fiscal year ends on December 31.
How much revenue did Prime Medicine, Inc. report?
Prime Medicine, Inc. reported $4.6M in revenue for calendar year 2025, according to its SEC filings.